Afficher la couverture 'Letter to the Editor: "Transdermal vs Oral Estrogen Therapy and Venous Thromboembolism: Upgrade the Level of Evidence" by | Scarabin, Pierre-Yves' en grand format
/5

0 avis

Letter to the Editor: "Transdermal vs Oral Estrogen Therapy and Venous Thromboembolism: Upgrade the Level of Evidence" by

Archive ouverte

Scarabin, Pierre-Yves | Canonico, Marianne | Scarabin-Carré, Valérie | Oger, Emmanuel

Edité par CCSD ; Endocrine Society -

International audience. Scarabin PY, et meta-analysis by Mohammed et al (1) confirms the safety advantage of transdermal vs oral estrogens with respect to the risk of venous thromboembolism (VTE). Surprisingly, the quality of evidence is described as very low (see Table 4 in the report). We believe that this quality rating based on “the observational nature of the studies and inconsistency of results” is not appropriate...

Consulter en ligne

Suggestions

Du même auteur

Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms.

Archive ouverte | Canonico, Marianne | CCSD

International audience. Editorial (no summary)

Hormone therapy and risk of venous thromboembolism among postmenopausal women

Archive ouverte | Canonico, Marianne | CCSD

International audience. Venous thromboembolism, either deep vein thrombosis or pulmonary embolism, is a serious side-effect of postmenopausal hormone therapy. Current use of oral estrogens increases the risk of veno...

Menopause and hormone therapy in the 21st century: why promote transdermal estradiol and progesterone?

Archive ouverte | Scarabin, Pierre-Yves | CCSD

International audience

Chargement des enrichissements...